NCT00593112View on ClinicalTrials.gov

Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate

PHASE4CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
ADHD
Interventions
DRUG

OROS methylphenidate

Concerta is given in capsule form with a minimum dose of 18 mg/day and a max of 126 mg/day. Subjects take Concerta once per day for 6 weeks.

OTHER

No intervention

No intervention

Trial Locations (1)

02138

Massachusetts General Hospital, Cambridge

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00593112 - Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate | Biotech Hunter | Biotech Hunter